AUPH
Price
$8.04
Change
-$0.14 (-1.71%)
Updated
Apr 3, 04:59 PM (EDT)
Capitalization
1.12B
27 days until earnings call
JSPR
Price
$4.02
Change
-$0.21 (-4.96%)
Updated
Apr 3, 04:59 PM (EDT)
Capitalization
60.54M
Ad is loading...

AUPH vs JSPR

Header iconAUPH vs JSPR Comparison
Open Charts AUPH vs JSPRBanner chart's image
Aurinia Pharmaceuticals
Price$8.04
Change-$0.14 (-1.71%)
Volume$14.73K
Capitalization1.12B
Jasper Therapeutics
Price$4.02
Change-$0.21 (-4.96%)
Volume$3.87K
Capitalization60.54M
AUPH vs JSPR Comparison Chart
Loading...
AUPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
JSPR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AUPH vs. JSPR commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AUPH is a StrongBuy and JSPR is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (AUPH: $8.05 vs. JSPR: $4.03)
Brand notoriety: AUPH and JSPR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AUPH: 94% vs. JSPR: 69%
Market capitalization -- AUPH: $1.12B vs. JSPR: $60.54M
AUPH [@Biotechnology] is valued at $1.12B. JSPR’s [@Biotechnology] market capitalization is $60.54M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AUPH’s FA Score shows that 0 FA rating(s) are green whileJSPR’s FA Score has 2 green FA rating(s).

  • AUPH’s FA Score: 0 green, 5 red.
  • JSPR’s FA Score: 2 green, 3 red.
According to our system of comparison, both AUPH and JSPR are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AUPH’s TA Score shows that 4 TA indicator(s) are bullish while JSPR’s TA Score has 4 bullish TA indicator(s).

  • AUPH’s TA Score: 4 bullish, 5 bearish.
  • JSPR’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, JSPR is a better buy in the short-term than AUPH.

Price Growth

AUPH (@Biotechnology) experienced а -4.85% price change this week, while JSPR (@Biotechnology) price change was -16.74% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.91%. For the same industry, the average monthly price growth was -11.19%, and the average quarterly price growth was -14.86%.

Reported Earning Dates

AUPH is expected to report earnings on May 01, 2025.

JSPR is expected to report earnings on May 10, 2024.

Industries' Descriptions

@Biotechnology (-8.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AUPH($1.13B) has a higher market cap than JSPR($60.5M). AUPH YTD gains are higher at: -8.797 vs. JSPR (-81.151). AUPH has higher annual earnings (EBITDA): 31.7M vs. JSPR (-74.87M). AUPH has more cash in the bank: 358M vs. JSPR (71.6M). JSPR has less debt than AUPH: JSPR (1.81M) vs AUPH (79.4M). AUPH has higher revenues than JSPR: AUPH (235M) vs JSPR (0).
AUPHJSPRAUPH / JSPR
Capitalization1.13B60.5M1,860%
EBITDA31.7M-74.87M-42%
Gain YTD-8.797-81.15111%
P/E Ratio204.75N/A-
Revenue235M0-
Total Cash358M71.6M500%
Total Debt79.4M1.81M4,379%
FUNDAMENTALS RATINGS
AUPH: Fundamental Ratings
AUPH
OUTLOOK RATING
1..100
19
VALUATION
overvalued / fair valued / undervalued
1..100
88
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
89
PRICE GROWTH RATING
1..100
46
P/E GROWTH RATING
1..100
40
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AUPHJSPR
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
75%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
59%
Momentum
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
65%
MACD
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
64%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
72%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
72%
Advances
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 18 days ago
70%
Declines
ODDS (%)
Bearish Trend 4 days ago
83%
Bearish Trend 3 days ago
82%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
73%
Bullish Trend 2 days ago
58%
Aroon
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
78%
View a ticker or compare two or three
Ad is loading...
AUPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
JSPR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AGVGX23.750.09
+0.38%
American Funds Global Insight F-2
HDSVX16.57N/A
N/A
Hodges Small Intrinsic Value Retail
LMPOX29.62N/A
N/A
ClearBridge Small Cap Growth R
NSVAX13.18N/A
N/A
Columbia Small Cap Value II Inst
PRCHX27.17N/A
N/A
T. Rowe Price Cap Apprec And Inc I

AUPH and

Correlation & Price change

A.I.dvisor indicates that over the last year, AUPH has been loosely correlated with JSPR. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if AUPH jumps, then JSPR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AUPH
1D Price
Change %
AUPH100%
+1.74%
JSPR - AUPH
44%
Loosely correlated
+2.17%
VCYT - AUPH
39%
Loosely correlated
+1.93%
CMRX - AUPH
37%
Loosely correlated
+0.24%
GOSS - AUPH
37%
Loosely correlated
-1.59%
CRDF - AUPH
35%
Loosely correlated
-1.63%
More

JSPR and

Correlation & Price change

A.I.dvisor indicates that over the last year, JSPR has been loosely correlated with AUPH. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if JSPR jumps, then AUPH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JSPR
1D Price
Change %
JSPR100%
-4.73%
AUPH - JSPR
44%
Loosely correlated
-1.71%
AVXL - JSPR
39%
Loosely correlated
-2.98%
ATNF - JSPR
38%
Loosely correlated
-12.00%
ABCL - JSPR
34%
Loosely correlated
-5.86%
MNMD - JSPR
34%
Loosely correlated
-7.04%
More